Skip to main content

Table 2 Numbers and percentage of participants receiving components of care at least once during 4 months of follow up by study arm

From: Active ingredients of a person-centred intervention for people on HIV treatment: analysis of mixed methods trial data

Service

Control % (n)

Intervention % (n)

X2 test and p value

Visit from spiritual leader

63·3 (38)

68·3 (41)

X2 = 0·33 p = 0·56

Discussion about spiritual worries

57 (34)

95 (57)

X2 = 24·1 p < 0·001

Prayer with staff

12 (7)

25 (15)

X2 = 3·56 p = 0·06

Emotional support from staff

80 (49)

100 (60)

Fisher’s exact p < 0·001

ART adherence counselling

92 (55)

98 (59)

Fisher’s exact p = 0·21

Time to talk to staff about worries

80 (48)

98 (59)

Fisher’s exact p < 0·001

Emotional support for family

55 (33)

98 (59)

Fisher’s exact p < 0·001

Discussion about pain

97 (58)

100 (60)

Fisher’s exact p = 0·50

Discussion about symptoms

98 (59)

100 (60)

Fisher’s exact p = 1·00

Non-opioid – paracetamol

100 (60)

98 (59)

Fisher’s exact p = 1·00

Weak opioid – codeine

18 (11)

60 (36)

X2 = 21·9 p < 0·001

Strong opioid – morphine

0 (0)

5 (3)

Fisher’s exact p = 0·24

Help with breathing problems

83 (50)

75 (45)

X2 = 1·26 p = 0·26

Anxiety medication

80 (48)

67 (40)

X2 = 2·72 p = 0·10

Nausea medication

88 (53)

88 (53)

X2 = 0·00 p = 1·00

Skin disorder medication

48 (29)

57 (34)

X2 = 0·84 p = 0·36

Diarrhoea medication

18 (11)

22 (13)

X2 = 0·21 p = 0·65

Constipation medication

12 (7)

27 (16)

X2 = 4·36 p = 0·04

Discussion about future

22 (13)

67 (40)

X2 = 24·6 p < 0·01

Planning ahead for family

22 (13)

65 (39)

X2 = 22·9 p < 0·001

Nutrition support

18 (30)

18 (30)

X2 = 0·00 p = 1·00

Financial support

7 (4)

5 (3)

Fisher’s exact p = 1·00